|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments required to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization expense | |||||
| Depreciation expense | |||||
| Stock-based compensation expense | |||||
| Change in fair value of the Convertible Loan | |||||
| Non-cash interest expense | |||||
| Non-cash interest income | |||||
| Gain on debt and Convertible Loan extinguishments | |||||
| Impairment expense | |||||
| Change in right-of-use asset | |||||
| Loss from disposal of property and equipment | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Accrued compensation | |||||
| Operating lease liability | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Proceeds from issuance of the Convertible Loan, net of issuance costs | |||||
| Proceeds from issuance of term debt, net of issuance costs | |||||
| Payments for taxes related to net share settlement of equity awards | |||||
| Proceeds from exercise of stock options | |||||
| Net cash provided by financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Right-of-use asset obtained by assuming operating lease liabilities | |||||
| Property and equipment included in accounts payable and accrued liabilities | |||||
Loading...